23 results on '"Berrang T"'
Search Results
2. Prospective Longitudinal Assessment of Quality of Life After Stereotactic Ablative Radiotherapy for Oligometastases: Analysis of the Population-based SABR-5 Phase II Trial
3. Polymetastatic Recurrence-Free Survival in Patients with Repeat Oligometastases on the SABR-5 Trial
4. Prospective Longitudinal Assessment of Quality of Life after Stereotactic Ablative Radiotherapy for Oligometastases: Analysis of the Population-Based SABR-5 Phase II Trial
5. OC-0268 Should OARs be prioritized in SABR for oligometastases? A secondary analysis of the SABR-5 trial
6. Validation of the Prognostic Utility of ESTRO/EORTC Oligometastatic Disease Classification: A Secondary Analysis From the Population-Based Phase II SABR-5 Trial
7. Predictors of Early Polymetastatic Relapse Following Stereotactic Ablative Radiotherapy for up to 5 Oligometastases: A Secondary Analysis of the Phase II SABR-5 Trial
8. Validation of the Prognostic Utility of ESTRO/EORTC Oligometastatic Disease Classification: A Secondary Analysis from the Population-Based Phase II SABR-5 Trial
9. Population Based Phase II Trial of Stereotactic Ablative Radiotherapy (SABR): Overall Survival Results of the SABR-5 Trial
10. Population Based Phase II Trial of Stereotactic Ablative Radiotherapy (SABR) for up to 5 Oligometastases: Preliminary Results of the SABR-5 Trial
11. EP-1616 Population-based Phase II Trial of Stereotactic Radiotherapy for up to 5 Oligometastases: SABR-5
12. Interim Toxicity Results From RAPID: A Randomized Trial of Accelerated Partial Breast Irradiation (APBI) Using 3D Conformal External Beam Radiation Therapy (3D CRT)
13. A Province-wide Quality Assurance (QA) Review of Stereotactic Body Radiation Therapy (SBRT) Treatment Planning for Lung Cancer
14. What is the User Variability of 3D Ultrasound for Image-guidance in Partial Breast Irradiation?
15. 164 DO HIGH PHYSICIAN OFFER RATES IMPROVE RECRUITMENT TO A CLINICAL TRIAL?
16. 107 CAN A FALSE NEGATIVE SENTINEL LYMPH NODE BIOPSY BE PREDICTED PRE-OPERATIVELY?
17. 95 OUTCOMES FOR PATIENTS WITH INOPERABLE EARLY STAGE NON-SMALL LUNG CANCER IN THE 3D PLANNING ERA
18. 106 ARE ‘HIGHER RISK’ BREAST CANCER PATIENTS LESS LIKELY TO BE OFFERED PARTIAL BREAST RADIOTHERAPY TRIAL PARTICIPATION?
19. Volumetric Arc Therapy (VMAT) Reduces Treatment Time Compared to Conventional IMRT (cIMRT) While Maintaining Similar Plan Quality in Whole Pelvic Gynecologic Radiotherapy
20. Can 3D Ultrasound Contribute to the Planning CT to Define the Target for Partial Breast Radiotherapy?
21. 327 Switching from water tank to real patient geometry - Impact clinical impact of implementation of Monte Carlo based treatment planning for electron beams
22. 190 Electron treatment of the nose — a comparison of Monte Carlo and water tank dosimetry
23. Prospective assessment of the relationship between traditional prognostic factors and novel biomarkers in prostate cancer patients treated with curative intent in a phase three randomized trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.